RHJA
COLL icon

Rice Hall James & Associates’s Collegium Pharmaceutical COLL Stock Holding History

Rice Hall James & Associates’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-276,847
Closed -$4.91M – 267
2022
Q2 		$4.91M Sell
276,847
-160,353
-37% -$2.7M 0.24% 86
2022
Q1 		$8.9M Sell
437,200
-267,001
-38% -$5.04M 0.35% 71
2021
Q4 		$13.2M Sell
704,201
-48,837
-6% -$952K 0.47% 53
2021
Q3 		$14.9M Sell
753,038
-46,260
-6% -$1M 0.55% 55
2021
Q2 		$18.9M Sell
799,298
-126,530
-14% -$2.92M 0.67% 51
2021
Q1 		$21.9M Buy
925,828
+4,903
+0.5% +$116K 0.72% 45
2020
Q4 		$18.4M Sell
920,925
-187,294
-17% -$3.66M 0.65% 48
2020
Q3 		$23.1M Buy
1,108,219
+111,601
+11% +$2.01M 0.93% 34
2020
Q2 		$17.4M Sell
996,618
-37,203
-4% -$728K 0.75% 45
2020
Q1 		$16.9M Sell
1,033,821
-22,565
-2% -$466K 0.94% 32
2019
Q4 		$21.7M Sell
1,056,386
-159,243
-13% -$2.65M 0.74% 43
2019
Q3 		$14M Sell
1,215,629
-45,061
-4% -$514K 0.5% 83
2019
Q2 		$16.6M Buy
1,260,690
+69,549
+6% +$930K 0.55% 65
2019
Q1 		$18M Buy
1,191,141
+259,015
+28% +$4.15M 0.58% 57
2018
Q4 		$16M Buy
932,126
+366,184
+65% +$6.27M 0.58% 59
2018
Q3 		$8.34M Buy
565,942
+129,432
+30% +$2.29M 0.3% 101
2018
Q2 		$10.4M Buy
436,510
+53,530
+14% +$1.32M 0.38% 91
2018
Q1 		$9.79M Buy
382,980
+50,393
+15% +$1.2M 0.38% 93
2017
Q4 		$6.14M Buy
332,587
+276,123
+489% +$3.95M 0.24% 105
2017
Q3 		$592K Buy
+56,464
New +$623K 0.03% 254

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Rice Hall James & Associates's COLL Position: Q3 2022 in Review

Rice Hall James & Associates sold out of Collegium Pharmaceutical (COLL) in Q3 2022, closing a stake of 276,847 shares — an estimated $4.91M sold.

Rice Hall James & Associates first reported a position in COLL in Q3 2017 and held it in 20 quarters. The position peaked at $23.1M in Q3 2020. 168 funds tracked by Wall St. Rank hold COLL as of Q3 2022.

  • Rice Hall James & Associates reported no remaining Collegium Pharmaceutical position as of Q3 2022 after selling out during the quarter.
  • Rice Hall James & Associates sold 276,847 Collegium Pharmaceutical shares in Q3 2022, an estimated $4.91M.
  • Rice Hall James & Associates first reported a position in Collegium Pharmaceutical in Q3 2017 and held it in 20 quarters.
  • Rice Hall James & Associates's Collegium Pharmaceutical position peaked at $23.1M in Q3 2020.
  • 168 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2022.

Based on Rice Hall James & Associates's 13F filing for Q3 2022, filed 1 Nov 2022.